Main menu

Transcriptome profiling of Korean colon cancer by cDNA PCR Nanopore sequencing


  • We have sequenced 20 pairs of Korean colon cancer patients using cDNA PCR Nanopore technology to identify colon cancer specific novel biomarkers that can be used for clinical usage.
  • We attempted to identify novel isoform, non-coding RNAs and fusion genes. Some candidates that were found were shown to have potential to be new colon cancer diagnostic biomarkers.
  • By using more precise and accurate data to detect such biomarkers, we want not only to be able to use them for clinical usage, but also to further propose a new molecular mechanism to better understand colon cancer tumorigenesis using Nanopore data.

Download the PDF

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

ナノポア技術

ナノポアの最新ニュースを購読 リソースと発表文献 Nanopore Communityとは

Oxford Nanoporeについて

ニュース 会社沿革 持続可能性 経営陣 メディアリソース & お問い合わせ先 投資家向け パートナー向け Oxford Nanopore社で働く 現在の募集状況 営業上の情報 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag